Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)

SHE:300519 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Net Income	52.1	50.39	64.36	108.82	114.28	98.98
Depreciation & Amortization	14.93	14.93	14.77	14.05	12.86	12.53
Loss (Gain) From Sale of Assets	0.07	0.07	0.29	-	0.71	-
Asset Writedown & Restructuring Costs	0.01	0.01	-0.02	-0	0.49	0.72
Loss (Gain) From Sale of Investments	-4.87	-4.87	-4.07	-4.32	-6.42	-6.59
Provision & Write-off of Bad Debts	0.11	0.11	-0.71	0.43	-	-
Other Operating Activities	1.63	0.39	0.5	0.2	-	-
Change in Accounts Receivable	-2.69	-2.69	14.4	-8.44	2.93	-0.51
Change in Inventory	1.69	1.69	-25.78	0.42	-4.46	6.08
Change in Accounts Payable	-6.55	-6.55	-10.6	15.37	22.02	1.53
Operating Cash Flow	56.39	53.43	53.29	126.43	142.36	112.61
Operating Cash Flow Growth	-12.08%	0.27%	-57.85%	-11.19%	26.41%	14.60%
Capital Expenditures	-2.81	-5.2	-15.99	-16.64	-14.71	-10.27
Sale of Property, Plant & Equipment	0.02	0.1	0.32	0.03	0.2	-
Investment in Securities	-30	-30	-40	10	-36.8	135.4
Other Investing Activities	4.84	5.14	4.29	4.55	6.78	18.75
Investing Cash Flow	-27.95	-29.96	-51.37	-2.07	-44.54	143.88
Common Dividends Paid	-64	-64	-80	-96	-96	-72
Financing Cash Flow	-64	-64	-80	-96	-96	-72
Net Cash Flow	-35.56	-40.53	-78.08	28.36	1.82	184.5
Free Cash Flow	53.58	48.23	37.3	109.78	127.64	102.34
Free Cash Flow Growth	14.95%	29.30%	-66.02%	-13.99%	24.72%	24.40%
Free Cash Flow Margin	20.58%	18.02%	13.80%	31.23%	39.78%	36.15%
Free Cash Flow Per Share	0.33	0.30	0.23	0.69	0.79	0.64
Cash Income Tax Paid	23.62	23.4	44.9	36	44.76	43.56
Levered Free Cash Flow	22.79	23.2	7.05	71.83	87.81	68.95
Unlevered Free Cash Flow	22.79	23.2	7.05	71.83	87.81	68.95
Change in Net Working Capital	6.53	6.55	22.28	-5.16	-21.71	-9.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.